Consistent with our finding, the study by Lan et al. [13] also reported that ANRIL knock-out can reduce cisplatin IC50 and increase gastric cancer cells’ chemosensitivity by modulating the expression of MDR-related genes, like MDR1 and MRP1. Liu et al. [31] revealed that LncRNA NEAT1/let-7a-5p axis can target Rsf-1 to regulate Ras-MAPK signaling pathway, and thereby modulating the cisplatin-sensitivity of nasopharyngeal carcinoma. The gene discussed is RSF1; the disease is gastric cancer.